Results-driven quality and regulatory affairs leader with 12+ years directing FDA, EU MDR, MHRA, TGA, Health Canada, PMDA, and ISO-compliant programs in medical devices, pharmaceuticals/supplements/cosmetics, clinical trials, and SaMD. Excelled in leading 510(k), De Novo submissions, clinical site audits, and GCP/ICH E6 (R2 & R3) oversight, achieving zero major findings in global inspections while slashing audit deficiencies by 60%. Built risk management frameworks (ISO 14971) and QMS from scratch, driving $347K+ in cost savings through Lean Six Sigma. Hold RAC Devices, CMQ/OE, CPHQ, LSSBB, and Lead Auditor certifications, in position to accelerate product approvals and ensure flawless compliance.